Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Loi, Sherene ^a,b   Haibe Kains, Benjamin ^a,c   Desmedt, Christine ^a   Wirapati, Pratyaksha ^d   Lallemand, Françoise ^a   Tutt, Andrew M ^e   Gillet, Cheryl ^e   Ellis, Paul ^e   Ryder, Kenneth ^e   Reid, James F ^f,h   Daidone, Maria G ^h   Pierotti, Marco A ^f,h   Berns, Els M J J ^g   Jansen, Maurice P H M ^g   Foekens, John A ^g   Delorenzi, Mauro ^d   Bontempi, Gianluca ^c   Piccart, Martine J ^a   Sotiriou, Christos ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e GUY S HOSPITAL   (United Kingdom)

^f FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DRUG RESPONSE; GENE CLUSTER; GENE EXPRESSION PROFILING; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MONOTHERAPY; PREDICTION; PROGNOSIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; FEMALE; GENETIC DATABASE; GENETICS; METABOLISM; NEOPLASM; STATISTICS; VALIDATION STUDY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN;

EID: 44949121510     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-239     Document Type: Article

References (24)

1. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Thorsen T Quist H Matese JC Brown PO Botstein D Eystein Lonning P Borresen-Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 2001, 98(19):10869-10874. 58566 11553815 10.1073/pnas.191367098
2. Sotiriou C Neo SY McShane LM Korn EL Long PM Jazaeri A Martiat P Fox SB Harris AL Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci U S A 2003, 100(18):10393-10398. 193572 12917485 10.1073/ pnas.1732912100
3. Michiels S Koscielny S Hill C Prediction of cancer outcome with microarrays: A multiple random validation strategy Lancet 2005, 365(9458):488-492. 10.1016/S0140-6736(05)17866-0 15705458
4. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 2005, 21(2):171-178. 10.1093/bioinformatics/bth469 15308542
5. Sotiriou C Wirapati P Loi S Harris A Fox S Smeds J Nordgren H Farmer P Praz V Haibe-Kains B Desmedt C Larsimont D Cardoso F Peterse H Nuyten D Buyse M Van de Vijver MJ Bergh J Piccart M Delorenzi M Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 2006, 98(4):262-272. 16478745
6. Loi S Haibe-Kains B Desmedt C Lallemand F Tutt AM Gillet C Ellis P Harris A Bergh J Foekens JA Klijn JG Larsimont D Buyse M Bontempi G Delorenzi M Piccart MJ Sotiriou C Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade J Clin Oncol 2007, 25(10):1239-1246. 10.1200/ JCO.2006.07.1522 17401012
7. Kittler J Hatef M Duin R Matas J On Combining Classifiers IEEE Transactions on Pattern Analysis and Machine Intelligence 1998, 10(3):226-238. 10.1109/34.667881
8. Haibe-Kains B Desmedt C Loi S Delorenzi M Sotiriou C Bontempi G Computational Intelligence in Clinical Oncology- a case study Studies in Computational Intelligence Springer-Verlag Smolinski TG, Milanova MM, Hassanien AE 2008 Applications of computational intelligence in bioinformatics and biomedicine:cUrrent trends and open problems
9. Davis CA Gerick F Hintermair V Friedel CC Fundel K Kuffner R Zimmer R Reliable gene signatures for microarray classification: Assessment of stability and performance Bioinformatics 2006, 22(19):2356-2363. 10.1093/ bioinformatics/btl400 16882647
10. Bolstad BM Irizarry RA Astrand M Speed TP A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/ 19.2.185 12538238
11. Ma XJ Wang Z Ryan PD Isakoff SJ Barmettler A Fuller A Muir B Mohapatra G Salunga R Tuggle JT Tran Y Tran D Tassin A Amon P Wang W Enright E Stecker K Estepa-Sabal E Smith B Younger J Balis U Michaelson J Bhan A Habin K Baer TM Brugge J Haber DA Erlander MG Sgroi DC A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen Cancer Cell 2004, 5(6):607-616. 10.1016/ j.ccr.2004.05.015 15193263
12. Reid JF Lusa L De Cecco L Coradini D Veneroni S Daidone MG Gariboldi M Pierotti MA Limits of predictive models using microarray data for breast cancer clinical treatment outcome J Natl Cancer Inst 2005, 97(12):927-930. 15956654
13. Jansen MP Foekens JA van Staveren IL Dirkzwager-Kiel MM Ritstier K Look MP Meijer-van Gelder ME Sieuwerts AM Portengen H Dorssers LC Klijn JG Berns EM Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling J Clin Oncol 2005, 23(4):732-740. 10.1200/JCO.2005.05.145 15681518
14. Praz V Jagannathan V Bucher P CleanEx: A database of heterogeneous gene expression data based on a consistent gene nomenclature Nucleic Acids Res 2004 32 Database issue D542 7 308841 14681477 10.1093/nar/gkh107
15. Cochrance WG Problems arising in the analysis of a series of similar experiments Journal of the Royal Statistical Society 1937, 4:102-118.
16. Team RCD The R Project for Statistical Computing http://www.r-project.org
17. Systems I Ingenuity Pathway Analysis http://www.ingenuity.com
18. Liu LT Peng JP Chang HC Hung WC RECK is a target of Epstein-Barr virus latent membrane protein 1 Oncogene 2003, 22(51):8263-8270. 10.1038/ sj.onc.1207157 14614450
19. Prasad A Fernandis AZ Rao Y Ganju RK Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells J Biol Chem 2004, 279(10):9115-9124. 10.1074/jbc.M308083200 14645233
20. Turner S J AS Cameron D Tamoxifen treatment failure in cancer and the nonlinear dynamics of TGFbeta J Theor Biol 2004, 229(1):101-111. 10.1016/ j.jtbi.2004.03.008 15178188
21. Bair E Tibshirani R Semi-supervised methods to predict patient survival from gene expression data PLoS Biol 2004, 2(4):E108. 387275 15094809 10.1371/journal.pbio.0020108
22. Park MY Hastie T Tibshirani R Averaged gene expressions for regression Biostatistics 2007, 8(2):212-227. 10.1093/biostatistics/kxl002 16698769
23. Oh DS Troester MA Usary J Hu Z He X Fan C Wu J Carey LA Perou CM Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers J Clin Oncol 2006, 24(11):1656-1664. 10.1200/ JCO.2005.03.2755 16505416
24. Paik S Shak S Tang G Kim C Baker J Cronin M Baehner FL Walker MG Watson D Park T Hiller W Fisher ER Wickerham DL Bryant J Wolmark N A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 2004, 351(27):2817-2826. 10.1056/NEJMoa041588 15591335